For: | Kidd M, Modlin I, Shapiro M, Camp R, Mane S, Usinger W, Murren J. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol 2007; 13(39): 5208-5216 [PMID: 17876891 DOI: 10.3748/wjg.v13.i39.5208] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i39/5208.htm |
Number | Citing Articles |
1 |
Janet L. Cunningham, Eva T. Janson. The biological hallmarks of ileal carcinoids. European Journal of Clinical Investigation 2011; 41(12): 1353 doi: 10.1111/j.1365-2362.2011.02537.x
|
2 |
Agoston T. Agoston, Robert D. Odze. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. 2015; : 1983 doi: 10.1017/9781139137201.028
|
3 |
Anna Koumarianou, Krystallenia I. Alexandraki, Göran Wallin, Gregory Kaltsas, Kosmas Daskalakis. Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review. Journal of Clinical Medicine 2020; 9(6): 1777 doi: 10.3390/jcm9061777
|
4 |
Haruki Senoo, Kiwamu Yoshikawa, Mayako Morii, Mitsutaka Miura, Katsuyuki Imai, Yoshihiro Mezaki. Hepatic stellate cell (vitamin A‐storing cell) and its relative – past, present and future. Cell Biology International 2010; 34(12): 1247 doi: 10.1042/CBI20100321
|
5 |
Florian Bösch, Annelore Altendorf-Hofmann, Vanessa Koliogiannis, Harun Ilhan, Sven Jacob, Elise Pretzsch, Svenja Nölting, Jens Werner, Frederick Klauschen, Christoph J. Auernhammer, Martin K. Angele, Thomas Knösel. Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms. Journal of Cancer Research and Clinical Oncology 2023; 149(5): 1895 doi: 10.1007/s00432-022-04119-6
|
6 |
Stefano La Rosa, Francesca Franzi, Luca Albarello, Anja Schmitt, Barbara Bernasconi, Maria Grazia Tibiletti, Giovanna Finzi, Claudia Placidi, Aurel Perren, Carlo Capella. Serotonin-Producing Enterochromaffin Cell Tumors of the Pancreas. Pancreas 2011; 40(6): 883 doi: 10.1097/MPA.0b013e31822041a9
|
7 |
Janet L Cunningham, Apostolos V Tsolakis, Annica Jacobson, Eva T Janson. Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of α-smooth muscle actin. European Journal of Endocrinology 2010; 163(4): 691 doi: 10.1530/EJE-10-0420
|
8 |
Anezka C. Rubin de Celis Ferrari, João Glasberg, Rachel P Riechelmann. Carcinoid syndrome: update on the pathophysiology and treatment. Clinics 2018; 73: e490s doi: 10.6061/clinics/2018/e490s
|
9 |
Andrew Leask, Sunil K. Parapuram, Xu Shi‐wen, D. J. Abraham. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio‐marker of fibroproliferative disease?. Journal of Cell Communication and Signaling 2009; 3(2): 89 doi: 10.1007/s12079-009-0037-7
|
10 |
Mark Kidd, Diego Ferone, Manuela Albertelli, Elena Nazzari, Lisa Bodei, Irvin M. Modlin. Neuroendocrine Tumors in Real Life. 2018; : 51 doi: 10.1007/978-3-319-59024-0_3
|
11 |
Olav A. Gressner. About coffee, cappuccino and connective tissue growth factor—Or how to protect your liver!?. Environmental Toxicology and Pharmacology 2009; 28(1): 1 doi: 10.1016/j.etap.2009.02.005
|
12 |
Andrej Udelnow, Doerthe Jechorek, Cora Wex, Silke Klose, Maciej Pech, Annegret Reinhold, Frank Meyer. Possible role of TGF β1 in inflammatory pseudotumor associated with multiple neuroendocrine tumors of the small intestine. Pathology - Research and Practice 2015; 211(10): 805 doi: 10.1016/j.prp.2015.06.005
|
13 |
Sung-Min Kang, Ji-Hoon Lee, Yun Suk Huh, Shuichi Takayama. Alginate Microencapsulation for Three-Dimensional In Vitro Cell Culture. ACS Biomaterials Science & Engineering 2021; 7(7): 2864 doi: 10.1021/acsbiomaterials.0c00457
|
14 |
Anne M. Rokstad, Björn I. Gustafsson, Terje Espevik, Ingunn Bakke, Roswitha Pfragner, Bernhard Svejda, Irvin M. Modlin, Mark Kidd. Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies. Cancer Science 2012; 103(7): 1230 doi: 10.1111/j.1349-7006.2012.02282.x
|
15 |
Shirley Andrea Ramírez Merlano, Mayra Alejandra Prada Serrano. Obstrucción intestinal por tumor neuroendocrino. Reporte de un caso. MedUNAB 2012; 15(3): 175 doi: 10.29375/01237047.1863
|
16 |
Faidon‐Marios Laskaratos, Krista Rombouts, Martyn Caplin, Christos Toumpanakis, Christina Thirlwell, Dalvinder Mandair. Neuroendocrine tumors and fibrosis: An unsolved mystery?. Cancer 2017; 123(24): 4770 doi: 10.1002/cncr.31079
|
17 |
Mark Kidd, Irvin Modlin, Kjell Öberg. Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms. Nature Reviews Clinical Oncology 2016; 13(11): 691 doi: 10.1038/nrclinonc.2016.85
|
18 |
Faidon-Marios Laskaratos, Ana Levi, Gert Schwach, Roswitha Pfragner, Andrew Hall, Dong Xia, Conrad von Stempel, Josephine Bretherton, Kessarin Thanapirom, Sarah Alexander, Olagunju Ogunbiyi, Jennifer Watkins, Tu Vinh Luong, Christos Toumpanakis, Dalvinder Mandair, Martyn Caplin, Krista Rombouts. Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine Neoplasms. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.629665
|
19 |
Olav A. Gressner. Less Smad2 is good for you! A scientific update on coffee's liver benefits #. Hepatology 2009; 50(3): 970 doi: 10.1002/hep.23097
|
20 |
Anela Blažević, Johannes Hofland, Leo J Hofland, Richard A Feelders, Wouter W de Herder. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum. Endocrine-Related Cancer 2018; 25(3): R115 doi: 10.1530/ERC-17-0380
|
21 |
Olav A. Gressner, Chunfang Gao, Katharina Rehbein, Birgit Lahme, Monika Siluschek, Thomas Berg, Tobias Müller, Axel M. Gressner. Elevated concentrations of 15‐deoxy‐Δ12,14‐prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ‐inducing drugs. Liver International 2009; 29(5): 730 doi: 10.1111/j.1478-3231.2008.01895.x
|
22 |
Bao Tung Pham, Wouter Tobias van Haaften, Dorenda Oosterhuis, Judith Nieken, Inge Anne Maria de Graaf, Peter Olinga. Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiological Reports 2015; 3(4): e12323 doi: 10.14814/phy2.12323
|
23 |
Mauro Cives, Francesca Rizzo, Valeria Simone, Francesca Bisceglia, Stefania Stucci, Andreas Seeber, Gilbert Spizzo, Tiziana Montrone, Leonardo Resta, Franco Silvestris. Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition. Neuroendocrinology 2016; 103(3-4): 321 doi: 10.1159/000438902
|
24 |
Faidon Marios Laskaratos, Leonidas Diamantopoulos, Martin Walker, Henry Walton, Mohamed Khalifa, Fatima El-Khouly, Apostolos Koffas, George Demetriou, Martyn Caplin, Christos Toumpanakis, Dalvinder Mandair. Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia. Neuroendocrinology 2018; 106(4): 366 doi: 10.1159/000486097
|
25 |
Deidi Strickland Bergestuen, Jørgen Gravning, Kristina Hermann Haugaa, Laura G Sahakyan, Svend Aakhus, Espen Thiis-Evensen, Erik Øie, Pål Aukrust, Håvard Attramadal, Thor Edvardsen. Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-6
|
26 |
Oana Ciobanu, Sorina Martin, Simona Fica. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review). Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10914
|
27 |
Jason R. Bylund, Han Qiong, Paul L. Crispen, Ramakrishna Venkatesh, Stephen E. Strup. Association of Clinical and Radiographic Features with Perinephric “Sticky” Fat. Journal of Endourology 2013; 27(3): 370 doi: 10.1089/end.2012.0205
|
28 |
Georgios A. Kanakis, Lars Grimelius, Dimitrios Papaioannou, Gregory Kaltsas, Apostolos V. Tsolakis. Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?. Oncotarget 2018; 9(32): 22653 doi: 10.18632/oncotarget.25203
|
29 |
Eleonora Pelle, Taymeyah Al‐Toubah, Brian Morse, Ghassan El‐Haddad, Jonathan Strosberg. Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy. Journal of Neuroendocrinology 2021; 33(2) doi: 10.1111/jne.12936
|
30 |
Kjell Öberg. Williams Textbook of Endocrinology. 2011; : 1809 doi: 10.1016/B978-1-4377-0324-5.00044-4
|
31 |
Roger K. Moreira, Kay Washington. Pathology of Gastrointestinal Neuroendocrine Tumors: An Update. Surgical Pathology Clinics 2010; 3(2): 327 doi: 10.1016/j.path.2010.05.003
|
32 |
Irvin M. Modlin, Björn I. Gustafsson, Ignat Drozdov, Boaz Nadler, Roswitha Pfragner, Mark Kidd. Principal Component Analysis, Hierarchical Clustering, and Decision Tree Assessment of Plasma mRNA and Hormone Levels as an Early Detection Strategy for Small Intestinal Neuroendocrine (Carcinoid) Tumors. Annals of Surgical Oncology 2009; 16(2): 487 doi: 10.1245/s10434-008-0251-1
|
33 |
Julia E. Wells, Meegan Howlett, Catherine H. Cole, Ursula R. Kees. Deregulated expression of connective tissue growth factor (CTGF/CCN2)is linked to poor outcome in human cancer. International Journal of Cancer 2015; 137(3): 504 doi: 10.1002/ijc.28972
|
34 |
Stefano La Rosa, Nora Sahnane, Laura Cimetti. Pancreatic Neuroendocrine Neoplasms. 2015; : 117 doi: 10.1007/978-3-319-17235-4_14
|
35 |
Thomas Cuny, Wouter de Herder, Anne Barlier, Leo J Hofland. Role of the tumor microenvironment in digestive neuroendocrine tumors. Endocrine-Related Cancer 2018; 25(11): R519 doi: 10.1530/ERC-18-0025
|
36 |
B.I. Gustafsson, O. Hauso, I. Drozdov, M. Kidd, I.M. Modlin. Carcinoid heart disease. International Journal of Cardiology 2008; 129(3): 318 doi: 10.1016/j.ijcard.2008.02.019
|
37 |
V Jahagirdar, Ali Kamal, R Steeds, John Ayuk. Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease. BMJ Case Reports 2016; : bcr2015213693 doi: 10.1136/bcr-2015-213693
|
38 |
Annica Jacobson, Janet L Cunningham. Connective tissue growth factor in tumor pathogenesis. Fibrogenesis & Tissue Repair 2012; 5(S1) doi: 10.1186/1755-1536-5-S1-S8
|
39 |
K Daskalakis, A Karakatsanis, P Stålberg, O Norlén, P Hellman. Clinical signs of fibrosis in small intestinal neuroendocrine tumours. Journal of British Surgery 2017; 104(1): 69 doi: 10.1002/bjs.10333
|
40 |
Irvin M. Modlin, Steven F. Moss, Daniel C. Chung, Robert T. Jensen, Elizabeth Snyderwine. Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine Tumors. JNCI: Journal of the National Cancer Institute 2008; 100(18): 1282 doi: 10.1093/jnci/djn275
|
41 |
Haruki Senoo, Yoshihiro Mezaki, Mutsunori Fujiwara. The stellate cell system (vitamin A-storing cell system). Anatomical Science International 2017; 92(4): 387 doi: 10.1007/s12565-017-0395-9
|
42 |
Maralyn Druce, Andrea Rockall, Ashley B. Grossman. Fibrosis and carcinoid syndrome: from causation to future therapy. Nature Reviews Endocrinology 2009; 5(5): 276 doi: 10.1038/nrendo.2009.51
|
43 |
Gowri M. Ratnayake, Faidon-Marios Laskaratos, Dalvinder Mandair, Martyn E. Caplin, Krista Rombouts, Christos Toumpanakis. What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?. Current Oncology Reports 2022; 24(10): 1281 doi: 10.1007/s11912-022-01211-5
|
44 |
Ildikó Klemmer, Shintaro Yagi, Olav A. Gressner. Oral application of 1,7‐dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis. Hepatology Research 2011; 41(11): 1094 doi: 10.1111/j.1872-034X.2011.00856.x
|
45 |
Bernhard Svejda, Mark Kidd, Francesco Giovinazzo, Karim Eltawil, Bjorn I Gustafsson, Roswitha Pfragner, Irvin M. Modlin. The 5‐HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer 2010; 116(12): 2902 doi: 10.1002/cncr.25049
|
46 |
Mauro Cives, Eleonora Pelle’, Davide Quaresmini, Francesca Maria Rizzo, Marco Tucci, Franco Silvestris. The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications. Neuroendocrinology 2019; 109(2): 83 doi: 10.1159/000497355
|
47 |
Faidon-Marios Laskaratos, Dalvinder Mandair, Andrew Hall, Sarah Alexander, Conrad von Stempel, Josephine Bretherton, TuVinh Luong, Jennifer Watkins, Olagunju Ogunbiyi, Krista Rombouts, Martyn Caplin, Christos Toumpanakis. Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms. Endocrine 2020; 67(3): 718 doi: 10.1007/s12020-019-02107-4
|
48 |
Mark Kidd, Ignat Drozdov, Richard Joseph, Roswitha Pfragner, Michael Culler, Irv Modlin. Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines. Cancer 2008; 113(4): 690 doi: 10.1002/cncr.23700
|
49 |
Kalle Landerholm, Sture Falkmer, Johannes Järhult. Epidemiology of Small Bowel Carcinoids in a Defined Population. World Journal of Surgery 2010; 34(7): 1500 doi: 10.1007/s00268-010-0519-z
|
50 |
Monjur Ahmed. Gastrointestinal neuroendocrine tumors in 2020. World Journal of Gastrointestinal Oncology 2020; 12(8): 791-807 doi: 10.4251/wjgo.v12.i8.791
|
51 |
Kjell Öberg. Williams Textbook of Endocrinology. 2016; : 1833 doi: 10.1016/B978-0-323-29738-7.00043-5
|